Management of Asymptomatic Lymphadenopathy on CT

Size-Based Management Algorithm

For asymptomatic patients with incidentally discovered lymphadenopathy on CT, no follow-up imaging is required for small nodes (<10 mm) with fatty hilum and oval shape, as these are considered benign 1, 2
Nodes >15 mm warrant investigation for potential malignancy, and those >25 mm are highly suspicious and typically pathologic 1, 2

Presence of fever, night sweats, or unintentional weight loss warrants immediate FDG PET/CT, regardless of node size, as these symptoms suggest lymphoma and require urgent evaluation 1, 2
Round shape, loss of fatty hilum, irregular borders, necrosis, or extranodal extension require immediate investigation 2

Young males with multiple subcentimeter nodes should prompt higher suspicion for lymphoma or metastatic germ cell tumors, and consider FDG PET/CT if multiple nodes or concerning features present 1
Patients with known extrapulmonary malignancy, smoking history, or immunosuppression warrant lower threshold for additional imaging 1, 3

For patients with high clinical suspicion for sarcoidosis, lymph node sampling is NOT recommended, and close clinical follow-up is a reasonable alternative 4, 5
Among patients with suspected sarcoidosis, 85% are confirmed to have sarcoidosis, but 1.9% have alternative diagnoses including tuberculosis and lymphoma 4, 5
For confirmed indolent mantle cell lymphoma with low tumor burden and Ki-67 <10%, a "watch-and-wait" approach is appropriate for asymptomatic patients 6

Do not rely on size alone, as normal-sized nodes can harbor microscopic disease, and enlarged nodes may be hyperplastic 2
Do not perform unnecessary biopsies on nodes with fatty hilum and benign morphology, which have extremely low malignancy risk 2
The sensitivity of CT for staging using size criteria alone is only 60-65% with specificity of 60-70% 1